ARTV vs FITB · $37.3M cap vs P/E 17, rev $3.37B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Fifth Third Bancorp (FITB) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
ARTV currently screens at market cap $37.3M. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Not investment advice. Open the ARTV and FITB stock pages for the full models.
Not investment advice.